Article

March is AMD Awareness Month

March is Age-Related Macular Degeneration (AMD) Awareness Month, and the American Academy of Ophthalmology (AAO), the American Society of Retina Specialists, the Macula Society, and the Retina Society have teamed up to encourage Americans to become more aware of their risks for AMD.

San Francisco

-March is Age-Related Macular Degeneration (AMD) Awareness Month, and the American Academy of Ophthalmology (AAO), the American Society of Retina Specialists, the Macula Society, and the Retina Society have teamed up to encourage Americans to become more aware of their risks for AMD.

Risk factors for AMD include having a family history of AMD; being aged 60 or more years; being overweight, hypertensive, or hypercholesterolemic; and being a smoker.

The Eye Smart Campaign, launched by the AAO and EyeCare America, recommends that adults with no signs or risk factors for AMD or other eye diseases have a baseline screening done at age 40. This is the age when the early signs of ocular disease and vision loss related to age may begin to become apparent. They also encourage all individuals, regardless of age, who have symptoms or risk factors for eye disease to see their ophthalmologists to determine the need and possibility of regularly scheduled screenings.

Early detection, careful monitoring, and prompt treatment are all critical pieces in the puzzle of AMD. Healthy lifestyle changes also can help patients who have AMD, according to the organizations. Decreasing exposure to ultraviolet (UV) light with UV-blocking glasses or hats, taking daily multivitamins, and eating fruits and dark-colored vegetables such as kale or spinach also may help reduce the risk of AMD, the groups said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.